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Abstract
Background: Cytokines have essential roles on intercellular communications and are effective in
using a variety of intracellular pathways. Among this multitude of signalling pathways, the NF-κB
(nuclear factor kappaB) and STAT (signal transducer and activator of transcription) families are
among the most frequently investigated because of their importance. Indeed, they have important
role in innate and adaptive immunity. Current techniques to study NF-κB and STAT rely on specific
ELISAs, Western Blots and – most recently described – flow cytometry; so far, investigation of such
signalling pathways are most commonly performed on homogeneous cells after purification.
Results: The present investigation aimed at developing a flow cytometry technique to study
transcription factors in various cellular types such as mixtures of B-cells, T-lymphocytes and
monocytes/macrophages stimulated in steady state conditions (in other words, as peripheral blood
mononuclear cells). To achieve this goal, a two step procedure was carried out; the first one
consisted of stimulating PBMCs with IL1β, sCD40L and/or IL10 in such a manner that optimal
stimulus was found for each cell subset (and subsequent signal transduction, therefore screened by
specific ELISA); the second step consisted of assessing confirmation and fine delineation of technical
conditions by specific Western-Blotting for either NF-κB or STAT products. We then went on to
sensitize the detection technique for mixed cells using 4 color flow cytometry.
Conclusion: In response to IL1β, or IL10, the levels of phosphorylated NF-κB and STAT3 –
respectively – increased significantly for all the studied cell types. In contrast, B-cells and
monocytes/macrophages – but, interestingly, not T-lymphocytes (in the context of PBMCs) –
responded significantly to sCD40L by increasing phosphorylated NF-κB.
Background
Cytokines have essential roles in positive, negative and
regulatory control of immune responses in every compart-
ment. The biological functions of cytokines mainly
depend on cytokine-mediated gene activation or repres-
sion. Studies on gene induction by different cytokines led
to the discovery of several signalling pathways including
NF-κB, STAT and others [1,2].
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Various types of specific or innate stimuli activate and
phosphorylate the latent cytoplasmic NF-κB/IκB complex,
which is ensued by the proteolysis of IκB. The NF-κB p65
sub-unit is then released; it is translocated to the nucleus
and binds the genes containing κB sites which in turn,
upregulates the expression of these gene products [2-6]. A
large variety of molecules are able to activate NF-κB such
as PAMPs, IL1, TNF, CD40L, BAFF [2,5]. Among activated
transcription factors, the NF-κB family is essential for
inflammation, innate and specific immunity, cell prolifer-
ation and apoptosis. NF-κB is involved in pro-inflamma-
tory cytokine secretion, anti-apoptotic gene expression
and cell proliferation, therefore, altered NF-κB expression
or regulation is involved in immune defaults resulting in
cancer [7-10] and chronic inflammatory diseases [11].
For the STAT signalling pathway, the process is slightly dif-
ferent than for NF-κB. The binding of certain cytokines
(such as IFN, some gp130, IL10, IL3 family, single chain
family, IL4...) [1,12] to cell-surface receptors results in
receptor dimerization and subsequent activation of JAK
tyrosine kinases, which are constitutively associated with
these receptors. Tyrosine residues on the receptor (intrac-
ellular) tails are then phosphorylated by activated JAKs
and serve as docking sites for a family of latent cytoplas-
mic transcription factors known as STATs. Members of the
STAT family are phophorylated by different JAKs (JAK1,
JAK2, JAK3 and TYK2) [1]; then, the relevant STAT dimer-
izes, subsequently leaves the receptor and translocates to
the nucleus, where it activates the corresponding gene
transcription. There are to date seven human STATs: STAT
1, STAT2, STAT3, STAT4, STAT5A, STAT5B and STAT6
[1,12-14].
Various solid tumors – as well as malignant hemopathies
(lymphomas and leukaemias) – in humans have been
shown to possess aberrant STAT activation. This property
is also found – and can be explored – in cell lines derived
from solid tumours or leukemias. For example, among the
STAT family, STAT3 is frequently activated in both multi-
ple myeloma cell lines [15,16] and tumors derived from
patient bone marrows [17]. STAT3 activation is required
for promotion of tumor cell survival and directly contrib-
utes to the malignant progression of multiple myeloma by
allowing accumulation of long-lived plasma cells [18-20].
The present investigation will focus on the two principal
intracellular pathways translocating into the nucleus – for
the first – the NF-κB activation pathway (mediated by the
integration of a cytokine-derived signal such as by IL-1β or
by sCD40L), and – for the other – JAK following activa-
tion of the STAT3 pathway (mediated by the integration of
a cytokine-derived signal such as by IL10). Those signal-
ling pathways represent the majority of cytokine-delivered
stimuli on receptors displayed on the surface of hemat-
opoietic cells and, by extention, of immune cells [21,22].
Currently, studying NF-κB and STAT3 is possible in ELISA
[23], Western Blot [24-26] and flow cytometry with puri-
fied cells [4]. The first disadvantage of these three tech-
niques is the pretreatment before analyzing: nuclear
isolation which takes a long time and requires an impor-
tant vigilance. The second disadvantage is the under-esti-
mation of the relationship between the different cellular
types. We thus aimed to examine nuclear factor transcrip-
tion during in vitro activation; this flow cytometry tech-
nique is convenient in most laboratories. This gave several
advantages (feasibility, sensitivity, reproducibility and
ease) over other measurements of nuclear factors (confo-
cal microscopy or EMSA). Thus, we developed a flow
cytometry technique that studies transcription factors of
different cellular types (B-cells, T-lymphocytes and mono-
cytes/macrophages) in homeostasis conditions, in other
words without preliminary cell purification. To validate
this technique, we compared our data with other tech-
niques.
We present here an original, convenient, and reproducible
technique to study various cell (B-cells, T-lymphocytes
and monocytes/macrophages) activation events (depend-
ing on membrane markers) through nuclear factor trans-
location (NF-κB and STAT3) by means of a novel, specific
flow cytometry assay. The stimuli chosen were IL1β and
sCD40L to activate the NF-κB pathway and IL10 to stimu-
late the STAT3 pathway. Furthermore, these cytokines
play a major role in immune responses. The originality of
this new technique consists in studying non-purified cells,
like some other studies [4,27] but various cells (such as
PBMCs) in a likely physiological context.
Results
Optimization of culture conditions and stimulation for 
studying transcription factors
As described, screening procedures to analyse phosphor-
ylated products of the NF-κB or STAT3 pathways prior to
flow cytometry, were performed using ELISA and Western
Blot techniques. The aim of those preliminary experi-
ments was double: -i) to set up optimized conditions of
cell stimulation; -ii) to obtain-conventional – baseline
data to be compared with results obtained in the novel –
target – technique using detection by flow cytometry.
Firstly, PBMCs were stimulated by various activators (i.e.
cytokines) at different times (Figure 1). To determine the
optimal concentration of each stimulus, we stimulated
PBMCs with each activator at various concentrations
(IL1β: 0 to 1000 ng/mL; sCD40L: 0 to 1000 ng/mL or
IL10: 0 to 200 ng/mL. After PBMC stimulation in 200 μL
complete medium for 48 hours at 37°C with 5% CO2,
individual culture supernatants were removed, filtered
(0.22 μm), and frozen until use. After, the cytokine IL-6BMC Molecular Biology 2007, 8:64 http://www.biomedcentral.com/1471-2199/8/64
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(PBMCs activation marker) was measured in individual
culture supernatants using commercial specific ELISA kits
(R&D Systems Europe Ltd) according to the manufac-
turer's instructions. Optimal concentration of PBMCs
stimulation was obtained with the following concentra-
tion, 50 ng/mL of IL1β, 50 ng/mL of sCD40L and 100 ng/
mL of IL10. The optimal concentration for each activator
conformed to standards in our laboratory [4,28]. In
unseparated cell culture conditions (i.e. PBMCs) we could
observe – by either ELISA or WB technique – that intracel-
lular pNF-κB concentration was increased following
PBMC stimulation with IL1β (Figure 1A, B) and with
sCD40L (Figure 1C, D). Maximum phosphorylation and
subsequent product detection was obtained for a 30 min
stimulation with 50 ng/mL of IL1β and sCD40L (p < 0.05)
for 106 cells (respectively, 0.988 ± 0.190 and 1.423 ±
0.464) versus unstimulated cells (respectively, 0.557 ±
0.044 and 0.212 ± 0.020). These conditions were consid-
ered to represent the baseline working culture conditions
from which to observe any significant difference of pNF-
κB concentration between non-activated PBMCs and
PBMCs activated by IL1β or sCD40L.
A similar screening protocol was set up to standardize an
optimal pSTAT3 PBMCs response following IL10 treat-
ment of PBMCs, using Western Blot and ELISA. We indeed
show (Figure 1E, F) that pSTAT3 concentration is ampli-
fied with IL10 stimulation: maximal signal product is
obtained after a 5 min exposure of PBMCs to IL10 stimu-
lation used at 100 ng/mL (1.724 ± 0.056) versus unstim-
ulated cells (0.568 ± 0.055). The same signal intensity is
achieved for all of the time exposures tested.
Development of an original flow cytometry technique to 
study nuclear transcription factors
Having identified optimal conditions for stimulating
unseparated PBMCs for the activation of the nuclear trans-
location factors pNF-κB and pSTAT3, we set up a flow
cytometry technique allowing the study of these nuclear
factors at the level of PBMC cellular subpopulations with-
out being obliged to purify these cellular subpopulations
in e.g. T-lymphocytes, B-cells, monocytes/macrophages,
as was previously a prerequisite.
We show an example of a cytogram that can be obtained
with this novel technique to detect transcription factors by
means of flow cytometry (Figure 2). The background sig-
nals were determined using relevant isotype control anti-
bodies (Figure 2A1, A4, A7 and 2C1, C4, C7). 7AAD
negative/pNFkB positive targets are cellular debris – not
e.g cytoplasmic NFkB signal. The blots were not always
clearly separated and individualized every time. As each
cell was not activated to the same extent or level, we were
able to observe the activation level from partially activated
cells, and from transiently activated cells or non activated
Western blot and ELISA analysis of phosphorylated NF-κB  and STAT3 in PBMCs Figure 1
Western blot and ELISA analysis of phosphorylated 
NF-κB and STAT3 in PBMCs. Western Blot of pNF-κB 
(A, C) and pSTAT3 (E) in PBMCs nuclear extract was 
observed with or without stimuli: IL1β (50 ng/mL) (A), 
sCD40L (50 ng/mL) (C) or IL10 (100 ng/mL) (E) for various 
periods (0 to 30 min). Data were representative of five 
experiments. pNF-κB and pSTAT3 were detected by ELISA 
(n = 5) in activated PBMCs nuclear extracts and the time 
dependant effect of the PBMCs stimulus was observed. 
PBMCs were stimulated for various periods of time (0 to 30 
min) with or without IL1β (B), sCD40L (D) or IL10 (F). Sta-
tistical significance (wilcoxon paired test; p < 0.05) was rep-
resented by an asterisk (*). Data represented the mean (± 
SD) of five experiments.
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Flow cytometry of simultaneous phosphorylated NF-κB and STAT3 expression from B-cells, T-lymphocytes and monocytes/ macrophages stimulated by IL1β (control) Figure 2
Flow cytometry of simultaneous phosphorylated NF-κB and STAT3 expression from B-cells, T-lymphocytes 
and monocytes/macrophages stimulated by IL1β (control). Cytogram (A and C) depicted one experiment and showed 
the isotype control (A1 and C1 for B-cells, A4 and C4 for T-lymphocytes and A7 and C7 for monocytes/macrophages). Cyto-
gram (A) showed the pNF-κB translocation of B-cells (A2, A3), T-lymphocytes (A5, A6) and monocytes/macrophages (A8, A9) 
with (A3, A6, A9) or without (A2, A5, A8) stimulus IL1β (50 ng/mL) for 30 min. Cytogram (C) showed the pSTAT3 transloca-
tion of B-cells (C2, C3), T-lymphocytes (C5, C6) and monocytes/macrophages (C8, C9) with (C3, C6, C9) or without (C2, C5, 
C8) stimulus IL1β (50 ng/mL) for 30 min. Data were representative of seven experiments. Summary of flow cytometry analysis 
(n = 7) of percentage of phosphorylated NF-κB (B) and phosphorylated STAT3 (D) activation (versus untreated) from B-cells, 
T-lymphocytes and monocytes/macrophages. The graphs represent the difference in percentage of phosphorylated nuclear fac-
tor between stimulated and untreated cells. Statistical significance (wilcoxon paired test; p < 0.05) was represented by an aster-
isk (*). Data represented the mean (± SD) of seven experiments.
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cells [29]. As can be seen in Figure 2A and 2C, within dif-
ferent unseparated PBMC subpopulations, CD19+ B-cells
(Figure 2A2, A3 and 2C2, C3), CD3+ T-lymphocytes (Fig-
ure 2A5, A6 and 2C5, C6), and CD14+ monocytes/macro-
phages (Figure 2A8, A9 and 2C8, C9) were cultured in the
presence (Figure 2A3, A6, A9 and 2C3, C6, C9) or absence
(Figure 2A2, A5, A8 and 2C2, C5, C8), of optimal concen-
trations of IL1β (50 ng/mL) for 30 min at 37°C (as
described previously). IL1β induced respectively an
increase in nuclear pNF-κB translocation by a magnitude
(vs baseline level), of 8.92 ± 2.73% for B-cells, of 3.93 ±
1.31% for T-lymphocytes and of 11.31 ± 6.22% for mono-
cytes/macrophages. However, IL1β did not induce any sig-
nificant increase of phosphorylated STAT3: 1.85 ± 0.18%
for B-cells, 0.69 ± 0.25 for T-lymphocytes and 0.10 ± 0.09
for monocytes/macrophages. The shown cytogram is rep-
resentative of seven independent experiments. The inte-
gration of the sum of individual results is represented in
the histograms shown in Figure 2B (NF-κB) and 2D
(STAT3): for all the diverse unseparated subpopulations,
the level of nuclear pNF-κB translocation increased signif-
icantly (p < 0.05) in response of IL1β under defined con-
ditions (this concerns equally B-cells, T-lymphocytes and
monocytes/macrophages) contrary to the level of nuclear
pSTAT3 translocation.
Induction of pNF-κB translocation following stimulation
with sCD40L used as predetermined, optimal concentra-
tions, was observed in B-cells and monocytes/macro-
phages – but, interestingly – not in T-lymphocytes;
phosphorylation of NF-κB was significantly (p < 0.05)
increased vs baseline levels, by a magnitude of 6.31 ±
1.64% in B-cells and of 11.75 ± 4.73% in monocytes/mac-
rophages (Figure 3A).
In parallel, Figure 3B represents the percentage of phos-
phorylated STAT3 of the various PBMC cell types in
response of optimal IL10 stimulation of unseparated cul-
tured cells. There is a significant (p < 0.05) increase (vs
baseline levels) of nuclear STAT3 translocation in each
cell type, by a magnitude of 25.85 ± 6.97% in B-cells, of
7.99 ± 4.67% in T-lymphocytes and of 11.00 ± 4.72% in
monocytes/macrophages.
Discussion
A recent review [30] states that the development of phos-
pho-specific intracellular detection necessitates develop-
ment of reagents and adapted protocols. Nuclear
translocation of transcription factors can be usually meas-
ured by immunoblotting of isolated nuclei by electro-
phoretic mobility shift assay (EMSA), or more recently in
flow cytometry on purified cells [4,27]. Aubry and cow-
orkers described in 2002 an original technique to study
the NF-κB pathway by multichannel flow cytometry after
permeabilisation of DCs stimulated with LPS [27]. Next,
our group contributed in 2003 an original approach to
study the phosphorylated transcription factor NF-κB in
purified B-cells populations originating from blood or
lymphoid tissues, with the need to purify the target cells
to homogeneity. The main problem of this technique is
the loss of information because of not studying cellular
events under physiological conditions. Now, we under-
stand the influence of the culture environment on any cell
and the importance of studying cells within their context.
So scientists need more and more techniques which study
specific cells in their environment. In this report, we have
developed and validated a flow cytometry to study tran-
scription factors for various cell subpopulations within
one cell type or a tissue suspension (we chose PBMCs),
because there is a need to study rapidly, commonly and
reproducibly such parameters (nuclear factor phosphor-
ylation/translocation) in blood samples representing
steady state or pathological conditions. Phosphorylation
of proteins in signal transduction is traditionally studied
by means of Western Blot Analysis and/or ELISA, which
carry valuable information regarding homogeneous or
Flow cytometry of simultaneous phosphorylated NF-κB and  STAT3 expression from B-cells, T-lymphocytes and mono- cytes/macrophages Figure 3
Flow cytometry of simultaneous phosphorylated NF-
κB and STAT3 expression from B-cells, T-lym-
phocytes and monocytes/macrophages. Summary of 
flow cytometry analysis (n = 7) of percentage of phosphor-
ylated NF-κB (A) and phosphorylated STAT3 (B) activation 
(versus untreated) from B-cells, T-lymphocytes and mono-
cytes/macrophages. PBMCs were stimulated for the appro-
priate time and concentration of sCD40L (A) and IL10 (B) (as 
identified previously). The graphs represent the difference in 
percentage of phosphorylated nuclear factor between stimu-
lated and untreated cells. Statistical significance (wilcoxon 
paired test; p < 0.05) was represented by an asterisk (*). 
Data represented the mean (± SD) of seven experiments.
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purified cell populations. The present study proposes an
original method to study phosphorylation of proteins in
complex, heterogeneous, cell populations such as unsepa-
rated PBMCs. This method could be further validated to
be applied to whole blood samples obtained from
patients presenting with inflammatory diseases, for exam-
ple, where there is a need to study cellular events [31].
Indeed, the NF-κB pathway plays a pivotal role in
immune and inflammatory responses and has attracted
much interest as a novel target for the treatment of inflam-
matory states. Meanwhile, the major interest resides in the
identification of cell subsets displaying altered nuclear
factor phosphorylation/translocation, thus to be clearly
identified by surface membrane characteristics.
Multiparameter flow cytometry offers the valuable advan-
tage of characterising, almost without doubt, certain cell
surface markers to identify subpopulations in response of
a stimulus. In this study, we used 3 labelling conditions:
one for each cell type, one for DNA gating and one for the
intracellular factor of interest. In this manner, we marked
only one cellular type and one intracellular factor per
tube. However, by using a flow cytometer with more exci-
tation lasers, it could be possible to mark DNA, all types
of cells and the 2 intracellular factors in the same tube.
Here we confirm that intracellular pathways of NF-κB and
STAT3 can be rather easily monitored by Western Blot and
ELISA (we thus took advantage of these reproducible tech-
niques to set up optimal conditions for the stimulation of
PBMCs with external signals leading to the use of either
NF-κB or STAT3, that are for instance IL1β and sCD40L
(NF-κB) and IL10 (STAT3), according to a general consen-
sus [23]. The development of a multiparameter flow
cytometry technique permits us to decipher which of the
stimulated cell population studied responded to treat-
ment. We evidenced that IL1β and sCD40L should be
used at 50 ng/mL for 30 min and IL10 at 100 ng/mL for
30 min. From the above experiments – principally aiming
at presenting a convenient technique for studying and
foremost tracing cellular translocation of – for the time
being NF-κB and STAT (but – hopefully – additional path-
ways such as other STATs and also SMAD) – we could pro-
vide evidence that unseparated monocytes/macrophages
responded strongly to sCD40L and B-cells to IL10. This
result is not surprising because the literature showed the
activation of PBMCs with these cytokines [32]. This study
has no real impact on the results but on the technique,
itself. The obtained results proved this method is valuable
to study activation of cells.
In flow cytometry, only 4 hours are necessary to prepare
the samples and roughly 1 hour to acquire and analyse the
data. It is the most feasible technique, however, the use of
the cytometer and analyse software require training. Flow
cytometry is not the most sensitive technique but the sen-
sitivity is largely acceptable (1 μg/tube). Relating to the
reproducibility, we observe a difference of the basal rate of
activation depending on the individual samples. Regu-
lated degradation of specific proteins is part of the intrac-
ellular biochemical changes that contribute to the
regulation of signal transduction pathways; NF-κB activa-
tion thus, requires the rapid degradation of IκBα, the
inhibitor of NF-κB. Before activation, NF-κB is seques-
tered in the cytoplasm by forming a complex with IκBα,
the nuclear translocation signal of NF-κB being masked by
the inhibitor. NF-κB can be activated by a number of stim-
uli, which trigger the phosphorylation of IκBα and lead to
the rapid dissociation of NF-κB from IκBα. Once released
from the IκBα complex, NF-κB immediately translocates
from the cytoplasm to the nucleus, where it mediates the
transcriptional activation of genes. At this point of phos-
phoprotein translocation, it is difficult to see the effective
translocation by flow cytometry. 7-Amino-Actinomycin D
(7-AAD) is a convenient, ready-to-use nucleic acid dye
that can be used in flow cytometric assays for exclusion of
nonviable cells, or to gate nuclei and label nucleic acids,
in replacement of propidium iodide (PI) in flow cytomet-
ric assays [4]. The advantage of 7-AAD over PI is its ability
to be used in conjunction with phycoerythrin (PE) – and
fluorescein isothiocyanate (FITC)-labelled monoclonal
antibodies in 2-color analysis, with minimal spectral over-
lap. Therefore, the relationship of basal degradation to
induced degradation remains uncertain [33]. Moreover,
NF-κB regulation of IκBα transcription represents a
delayed negative feedback loop that drives oscillations in
NF-κB translocation. Transcription of target genes
depended on oscillation persistence, involving cycles of
RelA phosphorylation and dephosphorylation [29]. The
oscillations in NF-κB signalling can explain the back-
ground levels of pNF-κB/pSTAT3 positive cells in unstim-
ulated PBMCs. Nevertheless, a similar difference between
stimulated and non stimulated cells is always detected.
This paper describes a novel flow cytometry method
which allows the detection and quantification of intranu-
clear levels of the transcription factors NF-κB and STAT3
in distinct PBMCs subpopulations; this technique enables
the identification of CD3, CD14 and/or CD19 subsets –
within unseparated PBMCs (and, maybe in the future,
whole blood cells) – which actually phosphorylate intra-
nuclear proteins upon appropriate stimulation. These
strategies will enable the development of simple though
robust blood methods to identify normal signalling path-
ways as well as impairments in phosphorylating proteins
in association with various human disease states (includ-
ing acute and chronic inflammatory conditions), or with
other chronic diseases characterized by an alteration of
the cytokine homeostatic milieu, as seen in profound
allergies or in cancer states [34].BMC Molecular Biology 2007, 8:64 http://www.biomedcentral.com/1471-2199/8/64
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In this way, our data stress the differences that are detect-
able between lymphocytes and monocytes regarding NF-
κB or STAT3 phosphorylation upon relevant stimulation;
an explanation could be because monocytes are associ-
ated with innate immune responses faster than, for exam-
ple, T or B-cells, an issue which would deserve closer
examination.
In summary, to determine the optimal conditions of acti-
vation, ELISA is the most practical technique to study at
the same time a large quantity of samples. Once the opti-
mal conditions have been identified, the Western Blot and
the flow cytometry technique become the most adequate
techniques, although the flow cytometry remains the
most rapid method.
Conclusion
Our technology to study transcription factors, such as
pNF-κB and/or pSTAT3, could be applicable to infrequent
cell subpopulations such as stem cell progenitors or other
cells with various stages of maturation/differentiation
[35]. Moreover, this original technology can be used to
detect transcription factor translocation; for example to
screen a new molecule that induces a cell response.
This flow cytometry technique is very interesting because
it can be applicable to different types of cellular relation-
ship studies, in particular in blood transfusion, immunol-
ogy and oncology. Indeed, this method could quantify the
activation of immune cells of a transfused person or of a
person who received platelets in order to better limit the
response. Concerning oncology, the NF-κB and STAT
pathways play important roles in tumorigenesis [36].
Thus, these intracellular pathways appear very interesting
to study in an oncological context. So, this new flow
cytometry technique appears very attractive for signal
study in PBMCs or tissue conditions.
Methods
Cell isolation
Human blood was obtained from healthy donors at the
Auvergne-Loire Regional Blood Bank. Peripheral Blood
Mononuclear Cells (PBMCs) were prepared from Buffy-
Coats as described previously [28]. PBMCs were isolated
by gradient density centrifugation using histopaque-1077
(Sigma-Aldrich, Saint Quentin Fallavier, France).
Cell stimulation
PBMCs were cultured at 20 × 106/mL in IMDM (Iscove
Modified Dulbecco's Medium) (Sigma-Aldrich) supple-
mented exactly as described previously [28]. PBMCs were
stimulated in the presence or absence of IL1β (AbCys,
Paris, France), purified – soluble – trimeric human CD40L
molecules (sCD40L) [37] (Alexis-Coger, Paris, France) or
IL10 (R&D System, Lille, France) at varying concentra-
tions: IL1β (0 to 200 ng/mL), sCD40L (0 to 200 ng/mL)
and IL10 (from 0 to 200 ng/mL) and for various time peri-
ods (0, 5, 15, 30 min). Stimulated PBMCs were incubated
in a humidified atmosphere at 37°C with 5% CO2.
Nuclear and cytoplasmic extraction
After incubation, PBMCs were washed with PBS contain-
ing 10% endotoxin-free FBS (Cambrex, Verviers, Bel-
gium). Washed cells were then treated with a nuclear
extract kit (Active Motif, Rixenart, Belgium) according to
the manufacturer's instructions. A cytoplasmic extract and
a nuclear extract for each culture condition were obtained
and conserved at -80°C until further assays.
Transcription factor ELISA
pNF-κB (phosphorylated NF-κB) p65 subunit and
pSTAT3 (phosphorylated STAT3) levels in nuclear extracts
from stimulated vs non-stimulated PBMCs were deter-
mined by ELISA for each PBMCs culture condition. pNF-
κB (assay sensitivity = 0.5 μg/well) and pSTAT3 (assay
sensitivity = 0.6 μg/well) was detected using a transcrip-
tion factor ELISA kit (Active Motif). Briefly, 2.5 μg of each
nuclear extract was incubated in 96-well plates containing
a consensus (5'-GGGACTTTCC-3') binding site for the
p65 subunit of pNF-κB. pNF-κB binding to the target oli-
gonucleotide was detected by incubation with a primary
antibody specific for the activated form of p65, and then
visualized by incubation with anti-IgG horseradish perox-
idase conjugate at optimal concentrations and a develop-
ing solution as described by the manufacturer, and
quantified at 450 nm with a reference wavelength of 655
nm (Multiskan EX, Labsystem, VWR International, Stras-
bourg, France). The principle is the same for pSTAT3 with
a specific consensus binding site (5'-TTCCCGGAA-3') and
transcription factor ELISA to detect STAT3 phosphoryla-
tion was performed as described by the manufacturer.
Detection of nuclear factors by Western Blot
Twenty-five micrograms of nuclear extract per well were
separated by 10% acrylamide gel (Sigma-Aldrich) and
transferred to a 0.45 μm nitrocellulose membrane (Amer-
sham Pharmacia, Orsay, France) by electroblotting using
transfer buffer supplemented with 20% methanol (Sigma-
Aldrich). Blots were blocked overnight at 4°C in PBS/
0.1% Tween 20/1% BSA (I.D. Bio, Limoges, France) and
incubated with a primary antibody to pNF-κB (0.4 μg/
mL) (Santa Cruz Biotechnology, Montrouge, France) or to
pSTAT3 (0.4 μg/mL) (Santa Cruz Biotechnology), for 90
min, at room temperature. Thereafter, the blots were
washed three times for 10 min with blocking buffer, then
incubated for other 90 min with the secondary horserad-
ish peroxidase-linked goat anti-rabbit antibody diluted at
1:5000 (Santa Cruz Biotechnology) as predetermined.
Then, blots were incubated with a chemiluminescent sub-
strate according to manufacturer's instructions (ECL;BMC Molecular Biology 2007, 8:64 http://www.biomedcentral.com/1471-2199/8/64
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Amersham Pharmacia) and finally exposed to radio-
graphic film (Sigma-Aldrich).
Detection of nuclear translocation by flow cytometry
After stimulation, PBMCs were washed with PBS contain-
ing 10% endotoxin-free FBS (BioWest) and fixed with
PBS/PAF 1% (Sigma-Aldrich) at room temperature for 20
min. (the same result was obtained at 37°C). PBMCs sub-
populations were labeled by FITC monoclonal antibodies
(5 μg/106 cells): CD19-FITC (BD Biosciences, Le Pont de
Claix, France) for B-cells, CD14-FITC (BD Biosciences) for
monocytes/macrophages and CD3-FITC (BD Biosciences)
for T-lymphocytes, in separated tubes at 4°C for 45 min.
After two washes, PBMCs were permeabilized by 0.03%
saponin (Sigma-Aldrich) at room temperature for 15 min.
After two washes in PBS/FBS, PBMCs were stained with PE
labeled-anti-pNF-κB antibody (2 μg/106  cells) (Santa
Cruz Biotechnology) or PE labeled-anti-pSTAT3 antibody
(2 μg/106 cells) (Santa Cruz Biotechnology) for 60 min at
room temperature. Then, PBMCs DNA was counter-
stained with 7AAD (0.25 μg/106 cells) (BD Biosciences) at
room temperature for 10 min. Finally, after washing in
PBS-FBS, PBMCs sub-populations were analyzed by flow
cytometry with a FACSCalibur (BD Biosciences). The soft-
ware used was CellQuest ProTM (BD Biosciences). A total
of 104 events was recorded for each sample. Experiments
were reproduced in order to set up conditions allowing
fine reproducibility of the technique with limited inter-
individual variation for a given culture condition.
Statistical analysis
Inter-experiment comparisons in stimulated vs unstimu-
lated PBMCs were analyzed by means of the Wilcoxon
paired test (StatviewTM, SAS Inst., Cary, NC). Differences
were considered statistically significant with values of p <
0.05.
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